Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Innovative Catheter Technology Repairs Leaky Tricuspid Valve

By HospiMedica International staff writers
Posted on 12 Oct 2016
An implantable annuloplasty band for treating mitral regurgitation (MR) has been used for the first time to repair a leaky tricuspid valve.

The Cardioband system offers a minimally invasive alternative to open heart surgery by combining a reconstruction implant with a transfemoral, transseptal catheter delivery system. The band itself has three elements: a polyester fabric sleeve, stainless steel anchors, and an adjustment mechanism inside the sleeve that allows homogeneous circumferential cinching after full deployment of the implant. The segmental deployment technique for affixing the band to the tissue ensures that Cardioband conforms to each patient’s specific annular geometry.

The Cardioband, which is available in six sizes, is connected to the posterior annulus, trigone to trigone, via the specially designed spiral anchors that worm their way into the tissue. Once the band has been secured with the anchors to the circumference of the annulus, it is reshaped under echocardiographic guidance using the adjustment mechanism, providing real-time fine-tuning on the beating heart itself, until the valve closes fully again. The Cardioband system is a product of Valtech Cardio (Or Yehuda, Israel), and has received the Conformite Europeenne (CE) mark of approval.

“As tricuspid insufficiency often arises as a consequence of diseases of the mitral valve, open heart procedures are a risky surgical intervention,” said Professor Francesco Maisano, MD, of The University Hospital of Zurich (Switzerland), who placed the first Cardioband on the tricuspid valve. “The Cardioband is a minimally invasive therapy which does not require the use of a heart-lung machine, reducing the impact on the patient and lowering the risk. Now, even patients previously thought to be inoperable can be treated.”

The tricuspid valve separates the right atrium of the heart from the right ventricle, preventing blood from flowing back into the atrium. Diseases of the tricuspid valve are much more rare than those of the mitral valve, its counterpart in the left half of the heart. A tricuspid insufficiency, where the valve fails to work properly, can lead to serious symptoms. The build-up of blood in the ventricle and the veins causes increased pressure on these organs, resulting in water retention in the legs and abdomen, liver damage, and potential atrial fibrillation (AF). Until now, the only treatment option for a leaky tricuspid valve was open-heart surgery using a heart-lung machine.

Related Links:
Valtech Cardio


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Cylindrical Water Scanning System
SunSCAN 3D
New
CPAP Machine
EcoStar Auto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new technology can make heart-related predictions more widely accessible through the use of wearables (Photo courtesy of Fred Zwicky/UIUC)

Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery

The heart's response to physical activity is a vital early indicator of changes in health, particularly in cardiovascular function and mortality. Extensive research has demonstrated a connection between... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.